Microfluidic Low-Input Fluidized-Bed Enabled ChIP-seq Device for Automated and Parallel Analysis of Histone...

Area of Science:

• Genomics
• Epigenetics
• Molecular Biology

Background:

• Genome-wide epigenetic modifications, including histone modifications, are crucial for gene regulation and implicated in diseases like cancer and inflammation.
• While chromatin immunoprecipitation followed by sequencing (ChIP-seq) has advanced, enabling analysis of scarce samples, its throughput remains a bottleneck.
• Existing low-input ChIP-seq methods lack rapid, high-throughput capabilities.

Purpose of the Study:

• To develop an automated, high-throughput platform for low-input chromatin immunoprecipitation followed by sequencing (ChIP-seq).
• To significantly reduce the time and cell input required for analyzing histone modifications.
• To enable comprehensive epigenetic profiling of low-abundance primary samples for precision medicine.

Main Methods:

• Development of LIFE-ChIP-seq (low-input fluidized-bed enabled ChIP-seq), a microfluidic platform.
• Automation of multiple ChIP assays for various histone marks.
• Assay optimization for minimal cell input (as few as 50 cells) and rapid processing (as little as 1 hour).

Main Results:

• Demonstration of LIFE-ChIP-seq, an automated and high-throughput microfluidic platform.
• Capability to process multiple ChIP assays on multiple histone marks simultaneously.
• Successful analysis of epigenetic modifications using as few as 50 cells per assay in as little as 1 hour.

Conclusions:

• LIFE-ChIP-seq significantly enhances the throughput of low-input ChIP-seq assays.
• The platform facilitates the analysis of a large number of samples and replicates from low-abundance primary tissues.
• This technology supports advancements in precision medicine by enabling detailed epigenetic profiling.